Predicting Biotech Breakouts Before They Happen

1

Review AI predictions of top biotech screened candidates.

2

Compare ROI, windows, scores, and price targets to guide your entries and stops.

3

Focus on AI summaries, charts, specifics, and comments to identify the theses you believe in — and act confidently, early.

🚀 Recent ScanScor Breakout Wins

These were predicted in advance. No hype. No guesswork. Just AI-powered precision. We predicted 13 confirmed breakouts from the first 130 tickers during the first 2 months following predictions establishing an official launch of ScanScor.com!

180 Life Sciences [ATNF]
1,853%
Equillium [EQ]
493%
NovaBay [NBY]
259%
Marker Thera [MRKR]
158%
Stem, Inc [STEM]
124%
Rigel Pharma [RIGL]
102%
Verastem [VSTM]
72%
Tonix Pharma [TNXP]
56%
BioXcel Thera [BTAI]
325%
Shattuck Labs [STTK]
194%
VivoSim Labs [VIVS]
186%
Ironwood Pharma [IRWD]
79%
XOMA Royalty [XOMA]
55%

This project is still very new (July 2025), and full access to predictions is still FREE! Many of the predicted time windows are still open and still others have not yet opened. The next breakout might be tomorrow. Join us while we prove the power of AI predictions resulting from thorough screening and carefully crafted prompts.

Create Free Account

On July 1st, 2025, we screened 640 biotech companies for signals that often come before major price movement. Ranking tickers was our first step in forecasting the initial sample of 124 (20%).

21,639

High R&D to Revenue Ratio

14,302

Cash Runway Risk

4,255

Revenue Growth Acceleration

3,685

Revenue Spike ≥20%

1,349

Net Income Breakout

20

Upcoming Clinical Trial (Phase 2)

13

Upcoming Clinical Trial (Phase 3)

Note: ScanScor also applies multipliers for Insider Trades, Analyst Ratings, and News Catalysts, which amplify these base counts into the composite scores used for ranking.

Each flag represents a measurable change in fundamentals that may indicate an emerging catalyst. Companies are ranked by how many of these indicators they’ve triggered. This process allows us to focus on the most obviously promising candidates for deeper analysis and prediction.

ScanScor’s Biomed Prediction Engine (BPE)—is a proprietary tool powered by AI and continuously refreshed data. We compress relevant data into finely tuned prompts for Orbo, our custom-trained AI model, which generates forward-looking predictions.

Predictions are updated as new data and catalysts emerge. Visit this page regularly to view Orbo’s successful forecasts, and join ScanScor for early access to approaching catalyst windows and high-potential breakout candidates.

🚀 See what Orbo, the AI behind ScanScor, thinks about our highest-ranked stocks. View the Reports Listings Page
BPE Predictions TODAY
0
We Recently Activated Orbo and the BPE
BPE Predictions this Month
7
Last 21 trading days
Ttl Unique Tickers
1399
Stocks Ranked and Queued for Prediction
Total AI Stock Analysis Sessions Recorded
132
AI is smarter with every report
Scroll to Top